Vaccine Delivery Devices Market Size is Anticipated to Grow at a CAGR of 7.6% By 2030

 

The global vaccine delivery devices market size is anticipated to reach USD 11.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 7.6% from 2025 to 2030. The market is primarily driven by growing immunization programs, financial support from government and non-government organizations, increasing vaccination initiatives and campaigns, and the rising prevalence of infectious diseases globally. Growing research in the field of vaccines and the development of new products are also contributing to the growth of the market.

The adoption of a needle-free approach for administering these products is gaining momentum due to the growing awareness and demand to avoid pain and injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling the market growth. The rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.

The Covid-19 epidemic significantly boosted the market growth, especially due to the increasing demand for vaccination to tackle the spread of the virus. Increasing investment in Research & Development by vaccination device manufacturers as well as the governments has expanded the market significantly at an accelerated pace. Initiatives are undertaken by various regulatory authorities like UNICEF, Gavi, and WHO are also expected to boost the market growth.

Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the U.K. government also announced funding of up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and the WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.

List Of Key Players in the Vaccine Delivery Devices Market

• Becton Dickinson & Company
• Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
• PharmaJet
• Vaxxas
• Gerresheimer AG
• SCHOTT AG
• Corium International, Inc.
• 3M

Request a free sample copy or view the report summary: Vaccine Delivery Devices Market Report

Vaccine Delivery Devices Market Report Highlights

• By device, the syringes segment held the largest revenue share in 2024 due to the increasing vaccination programs, spreading immunization coverage, and technological advancements 
• By route of administration, intradermal vaccination dominated the market in 2024 as the majority of vaccines are given through this route owing to its advantages 
• North America dominated the global market in 2024 owing to the increasing awareness levels, high adoption of technology, and the rising prevalence of infectious diseases

Vaccine Delivery Devices Market Segmentation

Grand View Research has segmented the global vaccine delivery devices market report on the basis of device, route of administration, and region:

Vaccine Delivery Devices Device Outlook (Revenue, USD Million, 2018 - 2030)

• Syringes
• Jet Injectors
• Other Devices

Vaccine Delivery Devices Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Intradermal Vaccination
• Intramuscular Vaccination
• Subcutaneous Vaccination
• Other Vaccinations

Vaccine Delivery Devices Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

 

About Us
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Non-opioid Pain Treatment Market To Reach $70.30 Billion By 2030

The global Non-Opioid Pain Treatment Market size is expected to reach USD 70.30 billion by 2030, registering a CAGR of 7.69% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to an increase in the prevalence of inflammatory diseases coupled with the robust product pipeline of novel non-opioid analgesics. According to the Centers for Disease Control and Prevention (CDC), around 32.5 million people are living with osteoarthritis condition in the U.S. In addition, according to the Spondylitis Association of America, about 3.2 million adult people in the U.S. have some form of Spondyloarthritis. 

Initiatives are undertaken by government & nonprofit organizations to promote the usage of safer alternatives to opioids such as NSAIDs to address the increasing demand for pain relieving medicines. For instance, in February 2022, the U.S.FDA issued draft guidelines to provide recommendations to pharmaceutical companies for developing NSAIDs for the treatment of acute pain lasting for 30 days. This initiative was a part of the government’s “HHS Overdose Prevention Strategy” which focuses on the prevention, reduction, treatment, and recovery of patients from an opioid overdose. Such an initiative is projected to fuel demand for NSAID drugs over the forecast period. 

Key market players are aggressively developing innovative techniques to meet the growing demand for NSAIDs for the management of pain. For instance, in June 2021, the University of Arizona developed oxytocin analogs for the treatment of patients suffering from. It is a bioavailable non-opioid pain relief product with the potential for inhaled administration. The development of such an innovative product is anticipated to drive non-opioid analgesics treatment market growth. 

In September 2022, the U.S. FDA recommended avoiding non-opioid analgesics treatment in pregnancy at 20 weeks due to the high chances of kidney problems in unborn babies. Such initiatives from governments may limit the prescription of NSAIDs, thereby, restraining non-opioid pain treatment market growth. 

Companies are adopting strategies such as new product development, launches, and partnerships to increase the penetration of non-opioid analgesic products. For instance, in March 2022, Vertex Pharmaceuticals announced positive results of its phase 2 clinical trial non-opioid pill that showed a significant reduction in post-operative acute pain. Successful completion of trial and subsequent approval of products is anticipated to drive non-opioid analgesics treatment market growth during the forecast period. 

The market is highly competitive and the competition in the market is expected to be high during the forecast period due to the presence of a large number of players. Key companies manufacturing generic NSAID products include GSK plc., Sun Pharmaceutical Industries Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Johnson & Johnson Services, Inc., amongst others. 

Request a free sample copy or view report summary: Non-opioid Pain Treatment Market Report

Non-opioid Pain Treatment Market Report Highlights

• In 2024, the NSAIDs segment accounted for the largest market share and is anticipated to maintain its dominance over the forecast period owing to the high demand for pain treatment and the commercialization of multiple NSAIDs in recent years
• Chronic pain was the accounted for highest share in 2024. Factors such as increasing product approvals, the high incidence rate of chronic pain, and high R&D initiatives for launching innovative NSAIDs products are leading to its dominance
• Based on route of administration type, the oral segment accounted for the highest share in 2024 owing to the easy administration and wide availability of orally administered NSAIDs products in the market
• Based on the distribution channel, retail pharmacies are expected to dominate the market with a 54.39% share in 2024. This dominance can be attributed to the presence of a large number of generic NSAIDs and their easy accessibility to patients due to the large presence of retail pharmacies network
• Asia Pacific region is expected to experience the fastest growth during the forecast period owing to an increase in penetration of NSAIDs products, rise in disposable income, and high disease prevalence of inflammatory diseases in developing countries 

Non-opioid Pain Treatment Market Segmentation

Grand View Research has segmented the global non-opioid pain treatment market based on drug class, pain, route of administration, distribution channels, and region:

Non-Opioid Pain Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)

• NSAIDs
• Non Selective NSAIDs
• Selective COX-2 Inhibitors
• Acetaminophen
• Local Anesthetics
• Other Drug Class

Non-Opioid Pain Treatment Pain Outlook (Revenue, USD Million, 2018 - 2030)

• Post-operative Pain
• Cancer Pain
• Chronic Pain
• Other Pain

Non-Opioid Pain Treatment Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral
• Topical
• Injectable
• Other Route of Administration

Non-Opioid Pain Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Non-Opioid Pain Treatment Regional Outlook (Revenue, USD Million, 2018–2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• Kuwait
• UAE

 

About Us
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

pH Meters Market To Reach $2.11 Billion By 2030 | CAGR 3.9%

 

The global pH meters market size is expected to reach USD 2.11 billion by 2030, registering a CAGR of 3.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key factors attributing to the market growth are introduction of technologically advanced portable and bench top pH meters, growing concerns to monitor environmental pollution and the need to regulate pH levels in various consumable products. 

Increasing demand for quality control and routine testing of soil, water, food, beverage, and dairy products is driving the use of new generation pH meters with multi-parameter analysis. The new devices are improving the efficiency, accuracy, ease of usage, and cost-effectiveness, which are expected to serve as high-impact rendering drivers over the forecast period. 

Increasing awareness regarding the need to regulate waste water pH in industries such as chemicals, pharmaceuticals, food processing, and other end use sectors is a key factor boosting the usage rates. pH neutralization of the waste water discharged from these industries is critical to prevent corrosion of sewage pipes and prevent leakage of harmful substances in to the land and other water bodies. 

Furthermore, growing awareness about soil pH and its impact on plant nutrient absorption is a key factor boosting the soil pH analysis. Maintaining the appropriate ratio of nitrogen, phosphorous, and potassium (N-P-K) in the soil plays an important role in improving the product yield, quality, and also improves resistance to various diseases. The shift towards scientific agricultural practices and growing demand for organic farming, soil testing, irrigational water testing, are some the key factors expected to positively reinforce market growth over the forecast period.

Request a free sample copy or view report summary: pH Meters Market Report

PH Meters Market Report Highlights

• The benchtop pH meters segment accounted for the largest revenue share of almost 43.2% in 2024, owing to its wide application in academic institutes, laboratories, and industrial researchers, ease of usage, and growing demand for easy accessibility and accuracy.
• The pharmaceuticals and biotechnology segment accounted for the largest revenue share in 2024, driven by several key factors.
• North America dominated with a share of 44.54% in 2024, driven by various factors that reflect the region's technological advancements and industrial demands.

pH Meters Market Segmentation

Grand View Research has segmented the global pH meters market on the basis of Product, application, and region:

pH Meters Product Outlook (Revenue, USD Million, 2018 - 2030)

• Benchtop pH Meter
• Portable pH Meter
• Continuous pH Meter

pH Meters Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceuticals and Biotechnology
• Environmental Research and Pollution Control
• Food Science
• Others

pH Meters Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Norway
• Denmark
• Sweden
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

List of Key Players of pH Meters Market

• Danaher Corporation
• Hanna Instruments
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Agilent Technologies
• Metrohm AG
• METTLER TOLEDO
• Merck KGaA
• Surtex Instruments Limited
• Mölnlycke Health Care AB

 

 

About Us
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Regulatory Information Management System Market Insights and Forecast By 2030

 

The global Regulatory Information Management System Market size is anticipated to reach USD 4.12 billion by 2030 and is projected to grow at a CAGR of 10.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of centralized RIMS among the pharmaceutical and medical device industry along with technological advancements would likely drive the market growth over the forecast period.

The pharmaceutical sector's rapid expansion to meet global demand for innovative drugs increases regulatory complexity. To address this, companies are investing in RIM technology, leveraging automation and Artificial Intelligence (AI) to enhance regulatory workflows. Trends include outsourcing, reliance on business interaction, and the use of high-quality data for intelligent applications. For instance, in August 2022, Calyx's long-term client Krka expanded its investment in the Calyx RIM system for over 5 years, signalling a positive industry shift toward RIMS technology for effective regulatory compliance management.

The integration of advanced technologies offers a lucrative opportunity for market growth. Leveraging cutting-edge technologies, such as AI, ML, & predictive analytics, significantly bolsters risk assessment and mitigation strategies. These advanced tools enable the RIMS to rapidly analyze vast datasets, identifying patterns and potential risks that might go unnoticed through traditional methods.

Moreover, the automation capabilities of these technologies streamline processes, reducing the likelihood of human error and providing real-time insights into emerging risks. Integrating blockchain technology further enhances data security and transparency in risk management processes. For instance, IQVIA unveiled IQVIA RIM Smart, the industry's first fully integrated, comprehensive regulatory information management system which is cloud-based. Machine learning (ML) and artificial intelligence (AI) are being used more and more by businesses to enable intelligent management of a product portfolio's whole regulatory lifecycle.

Companies operating in the market are increasingly entering into strategic partnerships with RIMS solution providers to leverage their expertise & guidance in understanding global regulatory submission requirements. For example, in May 2023, LexisNexis Reed Tech, known for its analytic and data management solutions in the life sciences industry, expanded its collaboration with RegDesk, a well-known RIMS provider. Such ongoing strategic initiatives by market players are expected to fuel the adoption of RIMS.

List of Key Players in the Regulatory Information Management System Market

• Veeva Systems
• Kalypso (Rockwell Automation)
• DDi
• Körber AG
• ArisGlobal
• PhlexGlobal
• AmpleLogic
• Calyx
• Amplexor Life Sciences
• Ennov
• MasterControl
• Rimsys
• Ithos Global Inc. (Cordance Group)
• LORENZ Life Sciences Group

Request a free sample copy or view report summary: Regulatory Information Management System Market Report

Regulatory Information Management System Market Report Highlights

• Based on end-use, the pharmaceutical segment led the market with the largest revenue share of 42.8% in 2023. This is attributed to implementation of strict regulation and need for RIM systems with streamlined, encrypted, unified, and compatible platforms. The medical device segment is expected to grow at the fastest CAGR over the forecast period
• North America dominated the market with the revenue share of over 37.1% in 2023, owing to an increase in advancement in the field of pharmaceutical, MedTech, and related sectors of end-of-life care, and growing awareness and rising demand for the RIM systems to bring in a better product for the end consumers/manufacturer’s
• With China, India, and Japan all expected to see rapid development throughout the forecast period, the Asia-Pacific region is expected to grow at the significant CAGR over the forecast period. These include rising rates of pharmaceutical-based products and medical devices and rising regulatory-related concerns. In addition, there has been an increase in the need for RIM-related software as a solution due to rising regulatory compliance and associated data maintenance requirements

Regulatory Information Management System Market Segmentation

Grand View Research has segmented the global regulatory information management system market report based on end-use, and region:

Regulatory Information Management System End-use Outlook (Revenue, Million, 2017 - 2030)

• Pharmaceutical Sector
• Medical Device Sector
• Other 

Regulatory Information Management System Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

• U.S
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Switzerland
• Sweden
• Denmark
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East and Africa (MEA)
• Saudi Arabia
• UAE
• South Africa
• Kuwait 

 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com